Prim-O-glucosylcimifugin
CAS: 80681-45-4
Ref. 3D-MP08135
5mg | 144,00 € | ||
10mg | 217,00 € | ||
25mg | 406,00 € | ||
50mg | 633,00 € | ||
100mg | 1.033,00 € |
Produktinformation
- 7-[(b-D-Glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-,(2S)-5H-furo[3,2-g][1]benzopyran-5-oneCimifugi n b-D-glucopyranoside
- (2S)-7-[(β-<span class="text-smallcaps">D</span>-Glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-5H-furo[3,2-g][1]benzopyran-5-one
- 5H-Furo[3,2-g][1]benzopyran-5-one, 7-[(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-, (2S)-
- 5H-Furo[3,2-g][1]benzopyran-5-one, 7-[(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-, (S)-
- Cimicifuga glycoside
- Cimifugin Beta-D-Glucopyranoside
Prim-O-glucosylcimifugin is a compound derived from Angelicae Dahuricae. This compound has been shown to have DNA binding activity in vitro and to inhibit the activity of an enzyme that is part of a signal pathway involved in viral replication. Prim-O-glucosylcimifugin has also been shown to be active against some infectious diseases, such as syncytial virus infection and HIV/AIDS. This compound also has anticomplement activity, which may be due to its ability to bind to C3b and C4b proteins on the surface of immune cells.
Chemische Eigenschaften
Technische Anfrage zu: 3D-MP08135 Prim-O-glucosylcimifugin
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.